简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-12-08 14:39 UVD Robots Wins EU Contract to Deploy 200 Robots in Hospitals Across Europe
2020-12-08 10:04 PPD Recognized as a Best Place to Work in Greater China
2020-12-08 09:55 Philip Morris International Announces U.S. Food and Drug Administration Authorization of IQOS 3 for Sale in the United States
2020-12-08 09:53 Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer
2020-12-07 15:58 GenesisCare Clinical CRO Adopts Veeva Vault Clinical Applications to Accelerate and Scale Studies Globally
2020-12-07 15:55 Rhizen Pharmaceuticals SA Announces Presentation of the Interim Results of the Phase I/II study of Tenalisib (RP6530) in Combination with Romidepsin in Relapsed/Refractory T-cell Lymphoma at American Society of Hematology (ASH) annual meeting, 2020
2020-12-07 09:51 New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint
2020-12-04 16:21 Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
2020-12-04 16:12 Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy
2020-12-03 16:20 PMI Commits to Disability Inclusion by Joining The Valuable 500
2020-12-03 15:24 CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New Form of App-based Prescription Treatment - The First Digital Therapeutic to Be Covered by Japan’s Public Healthcare Insurance System
2020-12-03 09:00 Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection; Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020
2020-12-02 17:57 Crest, Oral-B and Blend-a-med Announce the Launch of Their First Ever Recyclable HDPE Toothpaste Tubes in North America and Europe
2020-12-02 16:42 Market Access Transformation (MAT) Secures First Institutional Funding Led by Silversmith Capital Partners
2020-12-02 15:57 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets
2020-12-02 13:57 PCI Pharma Services Announces the Closing of the Majority Stake Acquisition by Kohlberg and Mubadala
2020-12-02 09:58 Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)
2020-12-02 09:54 LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor
2020-12-02 09:52 LianBio Announces Clearance to Initiate in China the Phase 2a Trial of Infigratinib in Patients with Locally Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma with FGFR2 Gene Amplification
2020-12-01 15:05 Study Comparing Two Noninvasive Indicators of Fluid Responsiveness on Mechanically Ventilated Patients Finds Masimo PVi® Effective and Advantageous

Business Wire Weibo

Press Releases

Latest Releases